Abu Dhabi, United Arab Emirates: Under the continued patronage of Her Highness Sheikha Fatima bint Mubarak, Imperial College London Diabetes Centre’s (ICLDC) hopes to engage more than 20,000 participants in its Walk 2018, the annual wellness event which highlights the benefits of healthier lifestyle choices across the Emirates, supported by the Department of Health - Abu Dhabi (DoH) and Abu Dhabi Sports Council (ADSC).

Now in its 12 th year, Walk 2018 takes place at Yas Marina Circuit on Friday, 16 November from 2pm, welcoming families and friends of all ages to join a 5km wellness walk encouraging more regular physical activity by residents of the UAE. ICLDC, in collaboration with other members of Mubadala’s network of healthcare providers including Cleveland Clinic Abu Dhabi and Healthpoint, will encourage the thousands of anticipated participants to join in range of dynamic activations including Zumba demonstrations, trampolines, bubble football, gladiator challenges, badminton and fitness sessions.

“Walk 2018 harnesses the power of the Abu Dhabi community to proactively address the increasing incidence of diabetes in the UAE, taking positive steps together to embrace wellbeing through active lifestyle choices,” said Lawrence Patrick, Chief Executive Officer at Imperial College London Diabetes Centre (ICLDC). “Attracting a wider and more engaged audience every year, Walk 2018 is the most visible and engaging element of ICLDC’s efforts to build awareness on prevention and management of diabetes, including the need for regular physical activity, balanced diet choices, and healthy weight management – we look forward to welcoming you to Walk 2018 on Friday, 16 November.”

As the UAE’s best-attended annual walkathon event, Walk 2018 is the cornerstone of ICLDC’s Diabetes.Knowledge.Action platform for increasing diabetes awareness in the UAE community. According to the International Diabetes Federation (IDF), more than one million people in the Emirates live with diabetes, and the prevalence of diabetes in the UAE is increasing faster than in the other Gulf states and worldwide. Authorities anticipate that the number of people with diabetes in the UAE will double to 2.2 million by 2040 ( http://www.icldc.ae/about-us/p/UAE-Diabetes-Trends ).

“Our collaboration with ICLDC on Walk 2018 underscores our commitment towards achieving our vision of a “healthier Abu Dhabi”, we are proud to work alongside ICLDC to further develop a sustainably healthy and engaged community in the Emirate of Abu Dhabi; one that takes responsibility for positive lifestyle choices such as regular physical activity and balanced diet choices. Together, we can take steps toward a future with fewer of the social and economic challenges caused by chronic diseases, including diabetes,” H.E Mohamed Al Hameli, Undersecretary of Department of Health Abu Dhabi (DoH).

“Awareness and action are among the most powerful tools to address the public health challenge posed by diabetes, and we are resolute supporters of Walk 2018 as a platform which delivers both of these beneficial outcomes for the UAE community,” said HE Aref Hamad Al Awani, General Secretary of Abu Dhabi Sports Council (ADSC).
Register today for Walk 2018 at https://www.premieronline.com/event/walkon2018 – entry is AED 10 for participants aged 16 and above. For more information please visit: http://www.walkon.ae/ or:

 Facebook: /DiabetesUAE
 Instagram: @Start_Walking
 Twitter: @Start_Walking
 Hashtag: #WalkOn

-Ends- 

About Imperial College London Diabetes Centre:
Imperial College London Diabetes Centre (ICLDC), part of Mubadala’s network of world-class healthcare providers, is a state-of-the-art outpatient facility that specialises in diabetes treatment, research, training and public health awareness. In just over a decade, the Centre has gained international renown for its holistic approach to the treatment of diabetes and related complications that enables patients to receive the full spectrum of care they need in one place.

With more than 80 diabetes professionals and endocrinologists under one roof, ICLDC offers best-in-class medical attention from first diagnosis to disease management across 11 specialist practice areas including adult and paediatric endocrinology, treatment of metabolic and electrolyte disorders, pre- and post-bariatric surgery care, heart disease prevention, nutritional advice, ophthalmology, nephrology and podiatry.

ICLDC was established in 2006 in Abu Dhabi by Mubadala in partnership with the UK’s Imperial College London to address the growing demand for diabetes care in the UAE. The centre now operates three branches across Abu Dhabi and Al Ain , touching the lives of more than one million people through patient-centric programmes and public health initiatives . In 2007, ICLDC launched Diabetes. Knowledge.Action, now the longest running public health awareness campaign in the country. The initiative promotes an active lifestyle through an ongoing calendar of events for the whole community – Major activations include an annual walkathon that coincides with the World Diabetes Day in November.

ICLDC holds the Joint Commission International (JCI) Clinical Care Program Certification in Outpatient Diabetes Management and JCI Accreditation for Ambulatory Care.

For more information, please visit www.icldc.ae

© Press Release 2018

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.